Duke University Hospital Pediatric Hematology/Oncology

Topics

• Hemoglobinopathies and Related Disorders 489
• Glioma Diagnosis and Treatment 343
• Hematopoietic Stem Cell Transplantation 166
• Acute Lymphoblastic Leukemia research 118
• Vascular Malformations and Hemangiomas 98
• Sarcoma Diagnosis and Treatment 92
• Childhood Cancer Survivors' Quality of Life 60
• Neuroblastoma Research and Treatments 56
• Cardiac and Coronary Surgery Techniques 54
• Wnt/β-catenin signaling in development and cancer 49
• Platelet Disorders and Treatments 42
• Lysosomal Storage Disorders Research 40

Most cited

1. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

   The New England journal of medicine · 2021 · 1,440 citations · Haydar Frangoul

2. Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.

   The New England journal of medicine · 2022 · 671 citations · Lowell Hart

3. Exagamglogene Autotemcel for Severe Sickle Cell Disease.

   The New England journal of medicine · 2024 · 351 citations · Haydar Frangoul, Lyndsay Molinari

4. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

   Nature medicine · 2024 · 168 citations · Daniel Landi

5. The multilayered transcriptional architecture of glioblastoma ecosystems.

   Nature genetics · 2025 · 96 citations · David Michael Ashley

6. Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia.

   The New England journal of medicine · 2024 · 174 citations · Haydar Frangoul